Order Article Reprints

Mihimit A, Adawaye C, Péré H, Costiniuk C, Koyalta D, Mbopi-Keou F-X, Bouassa R-SM, Talla F, Moussa S, Longo JDD, et al. HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon. Tropical Medicine and Infectious Disease. 2020; 5(3):136. https://doi.org/10.3390/tropicalmed5030136

Mihimit, Abdoulaye, Chatté Adawaye, Hélène Péré, Cecilia Costiniuk, Donato Koyalta, François-Xavier Mbopi-Keou, Ralph-Sydney Mboumba Bouassa, Frédéric Talla, Sandrine Moussa, Jean De Dieu Longo, and et al. 2020. "HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon" Tropical Medicine and Infectious Disease 5, no. 3: 136. https://doi.org/10.3390/tropicalmed5030136

Mihimit, A., Adawaye, C., Péré, H., Costiniuk, C., Koyalta, D., Mbopi-Keou, F.-X., Bouassa, R.-S. M., Talla, F., Moussa, S., Longo, J. D. D., Tchombou, B. H.-Z., Grésenguet, G., Charpentier, C., & Bélec, L. (2020). HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon. Tropical Medicine and Infectious Disease, 5(3), 136. https://doi.org/10.3390/tropicalmed5030136